Pharmaceutical Responding to the publication of the UK government position paper on science and innovation post-Brexit - Life Sciences Industrial Strategy, Elisabethann Wright, a partner at law firm Hogan Lovells, said: “Much of the focus in the paper is on current relationships between researchers in the UK and other EU member states which will hopefully continue after Brexit. However, the paper also discusses possible future bilateral relationships. 7 September 2017